COVID-19 and the Angiotensin-Converting Enzyme 1 D/I Genotype: Protection of People at High-Risk by Predicting the Severity of the Disease
Received Date: Aug 24, 2020 / Accepted Date: Sep 07, 2020 / Published Date: Sep 14, 2020
Abstract
Throughout history, humans have been threatened by various infectious diseases. As of August 22, 2020, a new coronavirus infection, COVID-19, has been raging around the world, infecting approximately 23 million people and killing approximately 800,000. Although COVID-19 is a serious infectious disease, it is at most comparable to the 1968 Hong Kong flu given the far more deaths caused by previous devastations, such as the plague, smallpox, Spanish flu, AIDS, tuberculosis and malaria. However, we are still in the midst of the epidemic, and it is difficult to project the extent of damage COVID-19 will ultimately inflict.
Keywords: COVID-19; Angiotensin; Infectious disease; Pathogenicity
Citation: Yamamoto N (2020) COVID-19 and the Angiotensin-Converting Enzyme 1 D/I Genotype: Protection of People at High-Risk by Predicting the Severity of the Disease. Diagn Pathol Open 5: 173. Doi: 10.4172/2476-2024.1000173
Copyright: © 2020 Yamamoto N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 1438
- [From(publication date): 0-2020 - May 17, 2024]
- Breakdown by view type
- HTML page views: 892
- PDF downloads: 546
